EUVIMEDEUVIMED entdecken
Crossref

Dehydroabietic acid protects against cerebral ischaemia–reperfusion injury by modulating microglia‐mediated neuroinflammation via targeting PKCδ

Luyao Li, Hao Tang, Lingyu She, Zhen Lin, Qin Yu, Yuqing Zeng, Linjie Chen, Fan Chen, Guang Liang iD, Xia Zhao, Namki Cho, Yi Wang

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Luyao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Microglia, Protein Kinase C-delta, Docosahexaenoic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: the Natural Science Foundation of Zhejiang province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Cerebral ischaemia–reperfusion injury (CIRI) is a major contributor to global morbidity and mortality, although its underlying mechanisms remain only partly understood. Emerging evidence indicates that inhibiting microglia‐mediated neuroinflammation would be an effective therapeutic approach for CIRI, and pharmacological interventions targeting this pathway hold significant therapeutic promise. This study aimed to identify a potent anti‐inflammatory drug from a natural compound library as a potential treatment for CIRI. Experimental Approach We used oxygen–glucose deprivation/reperfusion (OGD/R) and middle cerebral artery occlusion in male C57BL/6 mice to evaluate the efficacy of DHA in neurological deficits and the anti‐inflammatory effects. Using BV2 cells and murine brain tissue, liquid chromatography–tandem mass spectrometry was used to identify potential molecular targets of DHA, followed by bio‐layer interferometry, molecular docking, molecular dynamics simulations and cellular thermal shift assays to validate DHA's binding interactions with protein kinase C delta (PKCδ). Key Results DHA decreased production of pro‐inflammatory cytokines following OGD/R, thereby inhibiting microglia‐mediated neuroinflammation to protect neurons and reducing brain infarct size and improving neurological outcomes. Mechanistically, DHA directly bound to PKCδ, inhibiting its phosphorylation and downstream NF‐κB signalling. This binding interaction involved TRP 55 and LEU 106 on PKCδ, as confirmed by molecular docking and other biophysical techniques. Conclusion and Implications DHA specifically interacts with PKCδ, preventing its phosphorylation induced by ischaemia–reperfusion injury. These results suggest that DHA is a novel inhibitor of PKCδ and provide solid experimental foundations for using DHA in treating neuroinflammation‐related conditions, such as CIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryMicrogliaProtein Kinase C-deltaDocosahexaenoic AcidsNeuroprotective AgentsNeuroinflammatory DiseasesAnti-Inflammatory AgentsBrain IschemiaAnimalsMaleMice, Inbred C57BLMiceCell LineInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

PKCδcerebral ischaemia–reperfusion injurydehydroabietic acidmicroglianeuroinflammation

Substanzen

Protein Kinase C-deltaDocosahexaenoic AcidsNeuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • School of Pharmacy, Hangzhou Medical College, Hangzhou, China.
  • College of Pharmacy, Chonnam National University, Gwangju, South Korea.
  • School of Pharmacy, Hangzhou Normal University, Hangzhou, China.
  • Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.

ORCID-Profile: Guang Liang

Förderung

  • the Natural Science Foundation of Zhejiang province

Zitieren

APA

Li, L., Tang, H., She, L., Lin, Z., Yu, Q., Zeng, Y., Chen, L., Chen, F., Liang, G., Zhao, X., Cho, N., & Wang, Y. (2025). Dehydroabietic acid protects against cerebral ischaemia–reperfusion injury by modulating microglia‐mediated neuroinflammation via targeting PKCδ. British Journal of Pharmacology. https://doi.org/10.1111/bph.70030

Vancouver

Li L, Tang H, She L, Lin Z, Yu Q, Zeng Y, et al. Dehydroabietic acid protects against cerebral ischaemia–reperfusion injury by modulating microglia‐mediated neuroinflammation via targeting PKCδ. British Journal of Pharmacology. 2025. doi:10.1111/bph.70030

BibTeX
@article{Li2025,
  author = {Li, Luyao and Tang, Hao and She, Lingyu and Lin, Zhen and Yu, Qin and Zeng, Yuqing and Chen, Linjie and Chen, Fan and Liang, Guang and Zhao, Xia and Cho, Namki and Wang, Yi},
  title = {Dehydroabietic acid protects against cerebral ischaemia–reperfusion injury by modulating microglia‐mediated neuroinflammation via targeting PKCδ},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70030}
}
Kostenlos starten →